Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000834237-21-006814
Filing Date
2021-02-02
Accepted
2021-02-02 14:56:30
Documents
1

Document Format Files

Seq Description Document Type Size
1 us00773j1034_020221.txt SC 13G 11420
  Complete submission text file 0000834237-21-006814.txt   13165
Mailing Address 55 EAST 52ND STREET NEW YORK NY 10055
Business Address 55 EAST 52ND STREET NEW YORK NY 10055 212-810-5300
BlackRock Inc. (Filed by) CIK: 0001364742 (see all company filings)

EIN.: 320174431 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G
SIC: 6211 Security Brokers, Dealers & Flotation Companies

Mailing Address 805 LAS CIMAS PARKWAY SUITE 100 AUSTIN TX 78746
Business Address 805 LAS CIMAS PARKWAY SUITE 100 AUSTIN TX 78746 (512) 942-2935
Aeglea BioTherapeutics, Inc. (Subject) CIK: 0001636282 (see all company filings)

EIN.: 464312787 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-89456 | Film No.: 21580573
SIC: 2834 Pharmaceutical Preparations